Last edition
News about "Biocon generics portfolio"
Biocon Secures Health Canada Nod for Micafungin Injection
Biocon Pharma receives Health Canada approval for Micafungin for Injection (50 mg, 100 mg), strengthening its biosimilars and generics portfolio.
Biocon Generics Portfolio | 11/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members